Pierre Youinou and Rozenn Le Corre

The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus
Lupus 1999 8: 87-88. [PDF] [References]  

G R V Hughes

The Antiphospholipid Syndrome and ‘Multiple Sclerosis’
Lupus 1999 8: 89. [PDF] [References]  

K Ohtsuka, J D Gray, M M Stimmler, and D A Horwitz

The relationship between defects in lymphocyte production of transforming growth factor-ß1 in systemic lupus erythematosus and disease activity or severity
Lupus 1999 8: 90-94. [Abstract] [PDF] [References]  

K Ohtsuka, J D Gray, F P Quismorio, Jr, W Lee, and D A Horwitz

Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta
Lupus 1999 8: 95-102. [Abstract] [PDF] [References]  

F Tjernström, G Hellmer, O Nived, L Truedsson, and G Sturfelt

Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
Lupus 1999 8: 103-108. [Abstract] [PDF] [References]  

J W IJdo, A M Conti-Kelly, P Greco, M Abedi, M Amos, J M Provenzale, and T P Greco

Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
Lupus 1999 8: 109-115. [Abstract] [PDF] [References]  

J George, B Gilburd, P Langevitz, Y Levy, R Nezlin, D Harats, and Y Shoenfeld

ß2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels
Lupus 1999 8: 116-120. [Abstract] [PDF] [References]  

A Biasiolo, P Rampazzo, T Brocco, F Barbero, A Rosato, and V Pengo

[Anti-ß2 Glycoprotein I—ß2 Glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases
Lupus 1999 8: 121-126. [Abstract] [PDF] [References]  

J Chapman, M Cohen-Armon, Y Shoenfeld, and A D Korczyn

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes
Lupus 1999 8: 127-133. [Abstract] [PDF] [References]  

E Cucurull, L R Espinoza, E Mendez, J F Molina, J Molina, J Ordi-Ros, and A E Gharavi

Anticardiolipin and anti-ß2glycoprotein-I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and Spaniards
Lupus 1999 8: 134-141. [Abstract] [PDF] [References]  

R Wu, E Svenungsson, I Gunnarsson, B Andersson, I Lundberg, L Schäfer Elinder, and J Frostegård

Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
Lupus 1999 8: 142-150. [Abstract] [PDF] [References]  

A Fernández-Nebro, R Palacios-Muñoz, J Gordillo, M Abarca-Costalago, M De Haro-Liger, J Rodríguez-Andreu, and P González-Santos

Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study
Lupus 1999 8: 151-157. [Abstract] [PDF] [References]  

E A Mendez, L M Espinoza, M Harris, J Angulo, C V Sanders, and L R Espinoza

Systemic lupus erythematosus complicated by necrotizing fasciitis
Lupus 1999 8: 157-159. [Abstract] [PDF] [References]  

R M Morlá, M Ramos-Casals, M García-Carrasco, R Cervera, J Font, M Bruguera, J Rojas-Rodríguez, and M Ingelmo

Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature
Lupus 1999 8: 160-163. [Abstract] [PDF] [References]  

A Balbir-Gurman, D Schapira, and A M Nahir

Primary subcutaneous nocardial infection in a SLE patient
Lupus 1999 8: 164-167. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.